Scientists report that cancer cells and normal cells use different ‘gene switches’ in order to regulate the expression of genes that control growth. In mice, the removal of a large regulatory region linked to different types of cancer caused a dramatic resistance to tumor formation, but did not affect normal cell growth. The findings highlight the possibility of developing highly specific cancer drugs with fewer side effects.